Somedeb Ball

13PUBLICATIONS
86CO-AUTHORS
Regenerative medicine (incl. stem cells)Haematological tumoursMedical molecular engineering of nucleic acids and proteinsTime-series analysisMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 27, 2026
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).

|Apr 27, 2026
Chronic myelomonocytic leukemia beyond the marrow: biology, patterns, and management of extramedullary disease.

|Feb 11, 2026
Prognostic Model Combining Mutational and Cytogenetic Profiles in Acute Myeloid Leukemia Treated with Venetoclax and Hypomethylating Agents.

Dimitrios Drekolias, Fatima Tuz Zahra, Caroline Fileni

|Feb 04, 2026
Global Epidemiologic Trends of Early-Onset Cancers From 1990 to 2021 and Projection to 2040.

Rupayan Kundu, Ankush Mukhopadhyay, Niladri Kal

|May 05, 2023
Assessment and validation of the molecular international prognostic scoring system for myelodysplastic syndromes.

Luis E Aguirre, Najla Al Ali, David A Sallman

|Sep 15, 2022
Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutations.

Somedeb Ball, Todd C Knepper, Yehuda E Deutsch

Pageof 3

Frequent Collaborators

6 joint publications

Rami S Komrokji

5 joint publications

David Sallman

4 joint publications

Jeffrey Lancet

4 joint publications

Andrew T Kuykendall